Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma

<div>Surface expression of EGFR in human cancer cell lines. FACS was used to test the surface expression of EGFR proteins in human colon cancer SW620, HT29 cell lines, and renal cancer 786-O, ACHN, OSRC-2, and Ketr-3 cell lines.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma 